Qiu Mingjie, Li Jiayang, Wu Wenqi, Ren Jianan, Wu Xiuwen
Research Institute of General Surgery, Jinling Hospital, the Affiliated Hospital of Medical School, Nanjing Medical University, Nanjing, Jiangsu, China.
Research Institute of General Surgery, Jinling Hospital, the Affiliated Hospital of Medical School, Nanjing University, Nanjing, Jiangsu, China.
mBio. 2025 Jul 9;16(7):e0148125. doi: 10.1128/mbio.01481-25. Epub 2025 Jun 17.
Type I interferons (IFNs) are crucial components of the human immune system, playing a key role in regulating immune activity. Existing literature has characterized their antiviral and proviral roles in viral contexts. Type I IFNs also exhibit a dual role in bacterial infections, functioning as defenders or disruptors or both based on factors including but not limited to such things as the bacterial species, infection stage, host immune status, and the route and site of infection. This review provides a summary of the signaling pathways associated with type I IFN responses and discusses the complex mechanisms of type I IFNs in bacterial infections. Because type I IFNs provide an important opportunity to develop personalized treatment strategies, which are expected to be transformed into efficient adjuvant therapy for specific infectious diseases, we also discuss the potential for targeting type I IFNs for therapeutic interventions.
I型干扰素(IFN)是人类免疫系统的关键组成部分,在调节免疫活动中起关键作用。现有文献已描述了它们在病毒感染情况下的抗病毒和促病毒作用。I型干扰素在细菌感染中也表现出双重作用,根据包括但不限于细菌种类、感染阶段、宿主免疫状态以及感染途径和部位等因素,既作为防御者,也作为破坏者,或两者兼具。本综述总结了与I型干扰素反应相关的信号通路,并讨论了I型干扰素在细菌感染中的复杂机制。由于I型干扰素为制定个性化治疗策略提供了重要契机,有望转化为针对特定传染病的有效辅助治疗,因此我们还讨论了将I型干扰素作为治疗干预靶点的潜力。